Paglinawan, Jeverly I.
HRN: 04-31-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2025
METRONIDAZOLE 500MG (TAB)
02/04/2025
02/10/2025
PO
500 Mg
TID
Non Institutional Delivery
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes